Results for tag: "Bispecific Antibody Therapeutics Contract Manufacturing"

Bispecific Antibody Therapeutics Contract Manufacturing is a rapidly growing market within the oncology drugs sector. Bispecific antibodies are engineered to bind to two different antigens, allowing them to target and destroy cancer cells more effectively than traditional monoclonal antibodies. This has made them a promising tool in the fight against cancer, and has led to an increased demand for contract manufacturing services. Contract manufacturing services provide the necessary resources and expertise to develop and manufacture bispecific antibody therapeutics. This includes the production of cell lines, purification, formulation, and fill-finish services. Companies in this market include Lonza, Boehringer Ingelheim, and Fujifilm Diosynth Biotechnologies. Show Less Read more